Skye Bioscience, Inc. (SKYE)
1.79
-0.16
(-8.21%)
USD |
NASDAQ |
Aug 28, 16:00
1.79
0.00 (0.00%)
After-Hours: 16:15
Skye Bioscience EPS Diluted (TTM) : -10.18 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.18 |
| March 31, 2026 | -11.56 |
| December 31, 2025 | -11.28 |
| September 30, 2025 | -10.32 |
| June 30, 2025 | -8.550 |
| March 31, 2025 | -6.629 |
| December 31, 2024 | -5.823 |
| September 30, 2024 | -6.736 |
| June 30, 2024 | -31.26 |
| March 31, 2024 | -36.02 |
| December 31, 2023 | -45.57 |
| September 30, 2023 | -74.20 |
| June 30, 2023 | -61.50 |
| March 31, 2023 | -68.88 |
| December 31, 2022 | -70.18 |
| September 30, 2022 | -49.24 |
| June 30, 2022 | -45.44 |
| March 31, 2022 | -42.36 |
| December 31, 2021 | -42.90 |
| September 30, 2021 | -42.78 |
| June 30, 2021 | -47.34 |
| March 31, 2021 | -52.16 |
| December 31, 2020 | -65.04 |
| September 30, 2020 | -82.40 |
| June 30, 2020 | -69.06 |
| Date | Value |
|---|---|
| March 31, 2020 | 114.68 |
| December 31, 2019 | -82.24 |
| September 30, 2019 | -147.38 |
| June 30, 2019 | -179.24 |
| March 31, 2019 | -387.46 |
| December 31, 2018 | -344.84 |
| September 30, 2018 | -309.08 |
| June 30, 2018 | -317.18 |
| March 31, 2018 | -317.18 |
| December 31, 2017 | -317.18 |
| September 30, 2017 | -400.00 |
| June 30, 2017 | -460.00 |
| March 31, 2017 | -360.00 |
| December 31, 2016 | -340.00 |
| September 30, 2016 | -269.46 |
| June 30, 2016 | -309.46 |
| March 31, 2016 | -629.46 |
| December 31, 2015 | -589.46 |
| September 30, 2015 | -732.82 |
| June 30, 2015 | -660.62 |
| March 31, 2015 | -403.78 |
| December 31, 2014 | -282.93 |
| September 30, 2014 | -71.32 |
| April 30, 2014 | -3.720 |
| January 31, 2014 | 0.00 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.46 |
| Viking Therapeutics, Inc. | -4.662 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Savara, Inc. | -0.5766 |